Clonal hematopoiesis of indeterminate potential (CHIP) is a known risk factor for coronary artery disease, though its precise role in disease progression continues to emerge. This study leverages ...

Antibodies serve as foundational tools across a broad range of research fields from immunology to oncology and infectious ...

Cytek’s commitment to expanding access to advanced cytometry is a vital contribution to global public health. By supporting under-resourced labs, they’re helping ensure that essential research can ...

Background Globally, an estimated 296 million individuals live with chronic hepatitis B virus (HBV) infection, carrying ...

Circ-EGFR was identified as a novel predictive biomarker for cetuximab efficacy in KRAS wild-type metastatic colorectal ...

This study presents valuable findings on the role of KLF6 in in vitro endothelial cells exposed to altered (high or low) shear stress with a customized microfluidic device to investigate mechanisms of ...

GM is halting development of next-generation hydrogen fuel cells to double down on EVs, parting ways with Toyota and BMW’s continued investment in hydrogen tech. GM ends next-generation hydrogen fuel ...

Regeneron has given up on a CAR-T candidate acquired from 2seventy bio last year, before it entered the second part of a phase 1/2 lymphoma study. The dual-targeting CAR-T, dubbed bbT369, was being ...

OXFORD, England--(BUSINESS WIRE)--At the American Society of Human Genetics (ASHG) 2025 industry session on 16th October, Oxford Nanopore Technologies will share its latest developments in enabling ...

In a bulletin on Friday, GM announced that it will end its HYDROTEC brand's work on hydrogen fuel cell development. Instead, GM will focus its R&D efforts on batteries, charging technologies and ...